| Statins: The World Market 2010-2025 | | | | Comprehensive analysis of the world statins market |
| Where will opportunities lie for these prominent drugs | | | | Statins: The World Market 2010-2025 critically |
| after Lipitor's patent expiry? | | | | examines that sector through a comprehensive |
| Statins are potent cholesterol-lowering drugs, making | | | | review of information sources. We harness both |
| them important in the prevention of coronary heart | | | | primary and secondary research. This report provides |
| disease. Consequently, statins constitute one of the | | | | unique sales forecasts, market share analyses, |
| most important sectors of the pharmaceutical | | | | discussions of pipeline developments and analyses of |
| industry, with total revenues exceeding $25 billion in | | | | commercial drivers and restraints, including a SWOT |
| 2009. Our new report - Statins: The World Market | | | | analysis. There are over 70 tables and figures |
| 2010-2025 - provides detailed sales predictions and | | | | included, as well as two original interviews with |
| supporting discussions for this important | | | | relevant experts. The result is a comprehensive |
| pharmaceutical sector. ( ) | | | | market- and industry-centred study, with detailed |
| The world statins market is facing rapid change. From | | | | analyses to benefit your work. |
| 2010 onwards, there will be major patent expires | | | | Why you should buy Statins: The World Market |
| – most notably for Lipitor - maturity of products, | | | | 2010-2025 |
| and rising competition from generic alternatives. What | | | | In this report you will receive the following benefits in |
| are the crucial drivers and restraints in this market? | | | | particular: |
| Where will the best opportunities lie for both | | | | • You will assess the current market for statins |
| original-branded and generic products? When will | | | | • You will analyse the statins market of the |
| generic sales exceed branded? Who will be the new | | | | future, including a global sales forecast from 2010 to |
| market leader? Statins: The World Market 2010-2025 | | | | 2025, with informed discussions |
| answers those important questions and many others. | | | | • You will receive sales forecasts for leading |
| This analytical report provides essential information to | | | | brands and generic forms of statin drugs from 2010 |
| help you understand the statins market, with its | | | | to 2025, with detailed supporting information |
| marked commercial threats and opportunities this | | | | • You will receive sales forecasts for the leading |
| decade. | | | | companies in the statins market from 2010 to 2015 |
| This report covers the following statins in detail, | | | | • You will receive sales forecasts for leading |
| focussing on both commercial and therapeutic | | | | geographical markets from 2010 to 2025, with |
| prospects from 2010 to 2025: | | | | regional characteristics covered |
| • Simvastatin | | | | • You will examine commercial drivers and |
| • Atorvastatin | | | | restraints in depth |
| • Pravastatin | | | | • You will discover R&D pipeline |
| • Rosuvastatin | | | | developments in this sector |
| • Fluvastatin | | | | • You will read expert opinions from our original |
| • Lovastatin | | | | survey, with full interview transcripts. |
| • Pitavastatin. | | | | |